01Mar
March 2015
Cabinet Barny advised Kaldi Pharma, a subsidiary company of Domain Therapeutics, on the grant from Kaldi Pharma to Clevexel of a license to develop a potential preclinical drug candidate in Parkinson’s disease.
52, avenue des Vosges67000 Strasbourg
Tél. +33 (0)3 88 36 34 39
Fax. +33 (0)3 88 35 24 71